Thirdly, the state of the art metabolic assessment techniques, including body composition analysis and insulin sensitivity testing, allows for comprehensive and developmentally appropriate assessment of early cardiovascular disease and type 2 diabetes risk. The gene discussed is INS; the disease is type 2 diabetes mellitus.